Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 tampa general circle
Tampa, FL 33620
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Infectious Disease, 2019 - 2020
Orlando HealthFellowship, Infectious Disease, 2017 - 2019
HCA Florida Healthcare/Kendall HospitalResidency, Internal Medicine, 2014 - 2017
Medical University of LublinClass of 2014
Certifications & Licensure
FL State Medical License 2022 - 2026
TX State Medical License 2020 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsReal-world Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posac...Guy Handley, John Greene, Anthony P Cannella, Ana Paula Velez, Shivan Shah
Open Forum Infectious Diseases. 2024-05-01 - 1 citationsImpact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer.Ethan A Burns, Kelly Gee, Ryan B Kieser, Jiaqiong Xu, Yuqi Zhang
Cancers. 2022-12-23 - 10 citationsReal-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant.Hiba Dagher, Ray Hachem, Anne-Marie Chaftari, Ying Jiang, Shahnoor Ali
Journal of Fungi. 2022-01-13
Journal Articles
- Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posac...Guy Handley, MD, John Greene, MD, Anthony P Cannella, MD, MSc, Ana Paula Velez, MD, Shivan Shah, MD, Yanina Pasikhova, PharmD, Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels, 3/29/2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
